Wednesday - January 21, 2026

Category Archives: Professional Services

IBN Technologies Tax Preparation and Bookkeeping Fuel Smarter Moves for U.S. SMBs

Tax Preparation and Bookkeeping services [USA] IBN Technologies supports year-end tax efficiency through structured Tax Preparation and Bookkeeping services. Businesses benefit from proactive documentation support, strategic review cycles, and organized filing systems that align with year-end financial reporting goals and … Continue reading →

IBN Technologies’ Outsourcing Accounting and Bookkeeping Services Helps U.S. IT Companies Maintain Financial Stability

Outsourcing Accounting and Bookkeeping Services [USA] IBN Technologies provides outsourcing accounting and bookkeeping services tailored to the needs of U.S. IT firms. From recurring billing to reconciliation and reporting, their solutions help technology companies gain financial clarity, stay compliant, reduce … Continue reading →

IBN Technologies’ Outsourcing Accounting and Bookkeeping Services Helps U.S. Finance Firms Strengthen Accuracy

Outsourcing Accounting and Bookkeeping Services [USA] IBN Technologies offers specialized outsourcing accounting and bookkeeping services for U.S. finance firms, helping them manage compliance, streamline reporting, reduce audit risks, and improve operational clarity. Wealth advisors and financial consultants benefit from accurate … Continue reading →

Scleroderma Pipeline 2025: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | Bayer, Novartis, GSK, Boehringer Ingelheim, Celgene Corp., Johnson & Johnson, Prometic

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Scleroderma pipeline constitutes 40+ key companies continuously working towards developing 50+ Scleroderma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

Lassa Fever Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Inovio Pharma

  The Lassa Fever market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Lassa Fever pipeline products will significantly revolutionize the Lassa Fever market dynamics.   DelveInsight’s “Lassa … Continue reading →

Dystrophic Epidermolysis Bullosa Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Krystal Biotech, Chiesi, Phoenicis Therapeutics, Aegle Thera

Dystrophic Epidermolysis Bullosa pipeline constitutes 15+ key companies continuously working towards developing 15+ Dystrophic Epidermolysis Bullosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   “Dystrophic Epidermolysis Bullosa Pipeline Insight, 2025“ … Continue reading →

Non-Hodgkin Lymphoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma, Eli Lilly

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 180+ key companies continuously working towards developing 200 + Non-Hodgkin Lymphoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments … Continue reading →

Alcohol Use Disorder Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Alkermes, Teva Pharma, BioCorRx, Inc., Adial Pharma, ADDEX THER

Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Alcohol Use Disorder pipeline constitutes 30+ key companies continuously working towards developing 30+ Alcohol Use Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, … Continue reading →